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The aim of this study was to examine the roles of the 
TNF receptors p55 and p75 in the TNF-enhanced 
expression of collagenase by human dermal fibro-
blasts . The agonistic p55 monoclonal antibody Htr9 
and TNF induced production of similar amounts of 
collagenase. Polyclonal or monoclonal agonistic p75 
antibodies failed to enhance collagenase production, 
and the antagonistic p75 antibody 5E12 did not in-
hibit TNF-enhanced expression of collagenase. This 
strongly suggests that p55, but not p75, is involved in 
TNF-induced production of collagenase. Cells con-
tinued to produce an elevated level of collagenase 
F ibroblasts, like m os t other cell s, express the two TNF receptors (TNFRs) , p55 and p 75 (Tartaglia and Goed-d e l, 1992). T he signalin g p a thways activated b y the interaction b e tween T NF and the two T NFRs and the coope ration b etween the tWO recepto rs are sti ll subjec t 
to controversy (Vandenabeele el ai, 1995) . A p 55- specific TNF 
mutant induced lower collagen ase mRN A levels in d e rmal fibro-
blas t s than did TNF (Westermarck el ai, 1995), suggesting e ith e r a 
lower effectiveness of th e mutant or, alternatively, in vo lvem ent of 
the p75 recepto r in the indu c tio n of collagen ase prod uction. In thi s 
study we h ave investigated the ro le of each T N FR in the T N F-
e nhanced express io n of collagcn ase b y u sing antagonistic and 
agonistic p5 5- and p75-sp ecific antibo di es. A peptide en compassing 
residues 36-62 ofTNF (TNF 36-62) that indu ced ch e m o taxis in 
le ukocytes (Re kdal el fll , 1994) was in ves tig ated with rcspect to its 
ability to e nhancc co llagcn ;lse prod u ctio n ill c ulture d fibroblasts. 
MATERJ ALS AND M ETHODS 
Ma terials T he T NF 36 - 62 peptide was synthesizcd as prcviously de-
scribcd (Rckdal el ai, 1994), using Fmoc chemistry combined wi th a 
Milligen 9050 Plus Peps)'nthesize r (Mi ll ipore Corp ., \Vaters C hroma togra-
phy, Mil fo rd . MA). The peptide was purifIcd by reverse-phase high 
performance liquid chroma tograph y (Waters) and analyzed on a Fast Io n 
Bombard ment Mass Spectroscopy instrument (VG Anal),tica l. Manchester. 
Manuscript received February '12.1996; revised Jun e 18.1 996; accepted 
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Abbrev iatio ns: T N FR. TNF reccpto r; p55. low-altini ty TNFR: p75. 
high-affinity T N FR. 
after the removal ofTNF or Htr9. These data suggest 
that it may be useful to use specific inhibitors of 
collagenase rather than to block cytokine action 
directly in the treatment of diseases with chronic 
enhanced collagenolytic activity. A peptide of resi-
dues 36-62 ofTNF previously reported to be chemo-
tactic to leukocytes was also able to enhance the 
expression of collagenase activity by dermal fibro-
blasts. Thus, design of peptides with specific TNF 
effects Inay offer a novel approach for treatment of 
fibrotic disorders. Key IVo Jlds: C)'tokilles/peptide/mat"ix 
meta llop,'otei1lases. ] [livest D evma.toi 107:565-568, 1996 
UK). HUlllan recombinant TNF (Hr TNF), bovine se rum albumin , trypsin, 
soybean trypsin inhibi tor, ca lf th ymus DNA. 3,s-diamjnobenzoic acid , 
bacterial co ll age nas e. and rat tail co llagen were p urch ased fro l11 S ig l11 3 (St. 
Louis, MO). T he monoclonal an tibody (MoAb) H tr9 directed to TNF-
binding sites on TNFR ps 5 (Brock haus el al. 1990) was purchased £i'om 
Public Health Laboratory Service (London , UK). T he MoAb 3H 5 and the 
polyclonal p75 an tiseru m 1(624. w hich has becn described earl ier (Liabakk 
.'1 (/1, 1993; Espevik el ai, 1994; La:greid el ai, 1994), and 5E12, which is an 
analog of the antagonistic p75 MoAb Utrl (Brockhaus cl al. 1990; Espev ik 
cl ai, unpublished data), was kindly prov ided by Dr. T. Espevik. K624 was 
puri fIed on a Protein A Sephnrose co lumn by the method of E)' el al (1978). 
T he rabbit anti-mo use immunog lobulin Z4 12 was purchased /Tom Dako 
(G lostrup, Denmark). T he specificity of the antibod ies used in this study is 
sumnlari zed in Table I . 
Fibroblast Cultures Skin fibrob last cul tures were estab lished from 
biops ies fI'ont the m edial o r l;,teral aspect of upper arms. as the biopsy site 
did not aflec t the co llagenase prod ll cti on (\X/ illberg ci al. 1989). Ce ll s from 
the cultures were subcultivated as described prev iously (Winberg and 
Gedde-Dahl Jr, 1986; \1(I inberg N ai, 1994). and approxi mately 2 X 105 ce ll s 
were seeded per 12-dustcr we ll. After 36 h. the ce ll layers were was llCd 
three titHes w ith phosphate-bufFe red sa line. and the cul tu res were ntaiu-
ta ined for 24. 48, or 72 h in seru lll -free mod ified Du lbecco's medium with 
or w itho ut TNF, the TNF 36-62 peptide. antibodies. or different combi-
na tiollS of these reagents. After 24 h ill cuba tion w ith TNF or H tr9 . some 
cul tures were wash ed three tll11 CS \vith p h osp hate-buffered sa line before 
se rulll-free medium was added and co llected 48 h later. T he 3H5 antibody, 
which de tec ts a non-TNF binding site On the TNFR p75 . can mimic TNF 
activities w hen cross-linked by a seco lldary all ti- mo use an tibody (L:t!grcid ef 
(/1. 1994). T herefore, 3H 5 was added to the cul tures fo r I h at 4°C . 
Unbound 3 Hs was then removed by ",ashing wid] phosphate-bu lfered 
Silline, t h e secondary rabbit a n ti-mo ll se antibo d y Z ..J t 2 was added , and the 
cul tures were incubated for 48 h . l3eforc freez ing, the harvcsted mcdiulIJ 
was made 10 111M in CaClo and 100 m M in HEPES buller (pH 7.5) b)' the 
addition of 1 M HEPES (pH 7.5) conta ining 100 111M CaClo. In order to 
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Table 1. Characteristics of the Different Antibodies Used to Investigate the Involvement of TNFR in Enhancing the 
MMP Production by Human Fibroblasts 
Antibodies 
I-Itr9 
3H5 
Z412 
5E12 
K624 
Type 
Mouse IgG, 
Mo use IgG, 
Rabbit anti-mouse IgG 
Mouse [gG, 
Rabbit polyclonal 
;, When cross- linked with rabbit <1nti-lnollsc IgG. 
Specificity 
1'55 TNFR 
1'75 TNFR 
Mouse IgG, IgM 
1'75 TNFR. 
1'75 TNFR 
Activity 
Agon istic 
Agonistic" 
Cross-links mouse IgG 
Antagonistic 
Agonistic 
R eferences 
Brockhaus CI nl, 1994 
L"'gricd e( "I, 1994 
Dako, GlostTllp, Denmark 
T. Espcvik (unpublished)b 
Ll!gre id e( " I, 1994 
I, Dr. T cr:ic Espcv ik. Institute of Cancer Research. University of T rondhcim. N-7006 Trondhcim . Norway. 
normali ze data for enzyme synthesis, the cell laye r fi·om each well was 
trypsinized and the DNA content W'lS determined. DNA content was 
111casurcd by a fluorescence 1l1cthod utilizing 3,S-diantinobcnzoic acid 
Oohnson-W int and Hollis, 1982) with calf thymus DNA as a standard. No 
significant d ifferences in DNA were observed between treated and un-
treated cultures. 
Immunoreactive Collagenase Collagcnase produced by the fibrob lasts 
\VUS dctcnnincd by an inhibition cl1zYl11c-Unkcd imlTIul1osorbc l1t assay 
(ELISA) as described previously (Cooper c( ai, 1983), and a Biotrak ELISA 
as desc ribed by the manufacturer (Amersham, il uckinghamshire, England). 
BrieRy, in the inhibition ELISA, the conditioned medium was se rially 
diluted and mixed with anti-collagenase antibodies. T hese mixtures were 
incubated overnight at 4°C and centrifuged at 10,000 X g for 10 min; 150 
I.LI of the mixtures we re added in dupli cate to co llagenase-coated wells, and 
goat anti-rabbit IgG conjugated with alkaline phosphatase was added. In the 
direct ELISA (Amersham), serial dilutions of ce ll-conditioned media (100 
f.l-l) in duplicate were added to mouse 'll1ti-collagenasc antibody-coated 
well s. T hereafter, rabbit anti-coll ;lgcnase antibodies were added and were 
followed by donkey anti- r'lbbit IgG-conjugated peroxidase. 
Collagenase Activity Collagenase W'IS converted into the active form 
by limited proteolysis (Bauer "I "I, 1975; Winberg and Gcdde-Dahl Jr, 1986, 
'1992). Twenty microliters of trypsin (1.25 mg per ml) were added to 250 f.l-l 
of cell-condi tio ncd mediu111 and incubated for 15 min at 35°C. T hereafter, 
trypsin was inactivated by the addition of 14 p,1 of soybean trypsin inhibitor 
(50 mg per ml). Collagenase activity was determined against 100 p,g of 
reconstituted ' 4C-labeled rat tai l co llagen as substrate (25,000 cpm/mg 
collagen) (Winberg and Gedde-Dahl Jr, 1992). All assays were performed in 
dupli cate in 0 .1 M HEPES buffer (pH 7.5) at 35°C. One uni t of co ll agenase 
activity was defined as the amount of co llagenase needed to degrade 1 p,g 
of collagen per min. 
Stromclysin Activity Like coLlagenasc, stromclysin was converted into 
its active form by limited proteolysis with trypsin (0.2 mg per ml) for 30 min 
at 35°C (Winberg and Gcdde-Dahl Jr, 1992). Stromelysin activity was 
determined with azocasein as a substrate (Emonard " I nl, 1992; Winberg and 
Gedde Dahl Jr, 1992; Winberg cf ai, 1994). In the stromelysin assay, the 
enzymatic product released was separated from the substrate by the method 
of May and Elliott (1968). One unit of stromelysin activi ty was defined as 
the amount of enzyme that causes an increase of 0.001 units of absorbance 
<It 450 nm in 1 111in. 
Statistical Analysis Data were analyzed with the Student's t test and one 
w<ly ana lysis of variance. 
RESULTS 
TNF Enhanced the Expression of Immunoreactive Collage -
nase and Collagenase and Strol11elysin Activity Con centra-
tions frOI11 0.6 to 1.2 nM (10-20 ng per 1111) TNF resu lted in a a 6-
to 9-fold in crease in immunoreactive collagenase. Since 0.6 nM 
appeared to be close to an optimal con centration of TNF, this 
concentratio n was u sed in additio nal studies. As shown in Table n , 
the change in the amount of collagenase released was reflected in a 
similar c hange in collagenase activity. In addition , TNF enhan ced 
stromelysin activity approximately 3-fold over controls. Condi-
tioned medium that had not been treated with trypsin did not 
degrade the reconstituted coHagen gels or the azocaseinase sub-
strate, indicating that o nly procollagenase and prostromelysin were 
expressed b y both T NF-stimulated and un sti mul ated cells . These 
results also indicate that TNF did not stimulate the production of 
metalloproteinase activators . 
Synthetic TNF 36-62 Peptide Enhanced the Expression of 
Collagenase The T NF 36-62 p eptide induced a significant 
increase in collagenase production (p < 0 .05) in cu ltured fibroblas ts 
after 48 h (Fig 1). The effect was concen tration-dependent, and the 
highest con centration tested (100 f-LM) produced an increase of 
about 2.5-fold, which was about 65'X, of the iJ1CreaSe produced b y 
0.6 nM T NF in the sam e experiment. T h e lowest con centration 
tested (0.5 f-LM) resulted in an increase in collagena se activity of 
1.3-fold over that of controls. 
TNF-Enhanced Expression of Collagenase Is Mediated 
Through the p55 Receptor Several antagonistic and agonistic 
p55 and p75 antibodies were used to determine which of th e two 
TNFRs mediate TNF-induced produ ction of collagen ase in cul-
tured fibroblasts. These anti b odies have been used previously to 
study th e contribution of the two T NFRs in different T NF activities 
Table II. TNF induced production of MMP by Human Dermal Fibroblasts" 
Immunoreactive Collagcnascf 
TNF 
(ng/1111) ng/ml Relative Values 
0 N.D:' 1.0 ± 0.1" 
10 N.D. 5.5 ± 0.1" 
0 62 ± 2' 
10 573 ± 28" 9.2 
Collagenase Activity"J 
mU 
3.2 ± 0.5 
18.3 ± 0.4" 
5.7 ± 0.6 
37 ± 1" 
Relative Values 
1 
5.7 
6.5 
Stromelysin Activity,J 
mU 
NO 
NO 
95 ± 5 
287 ± 1" 
Relative Values 
ND 
NO 
1 
3.0 
/I Norma l hUll1illl skin fibroblasts we re incubated for 48 Ii in the presence or absence ofTNF. The am ount ofillunlill orcacrivc collagellase waS determined by either "iuhibition 
o r rdircct ELISA. 
(/ T he coll agcI1;Isc acti vity was determined by the degradation of reconstituted collagen fibri ls ~lt 24 h incubation at 35°C. Each gel cOlltllincd 2500 Cplll ;15 showll by tot:U 
degradation lIsing bacterial collagenase ill a finnl concentration of 50 J-Lg/ml. 
.. T he stromclys in activity was dete rmin ed lIsing azocasei n as substrate. 
f Mcan ::t SO . 
• 1.' ND. not determ ined. 
1/ Compared with control p < 0.05 . 
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Figure 1. TNF 36-62 enhanced collagenase production by human 
dermal fibroblasts. After 36 h. conAucnt cultures of normal dermal 
fibrob lasts were incubated for 48 h in the prescnce or absence ofTNF (10 
ng per ml) and TNF 36-62 at the indicated concentrations and assayed for 
coll agenase activity as dcscribed in Mnterinls nlld Methods. R.esu lts arc 
presented as relative va lues (mean :!: SD) comparcd to unstimulatcd cclls 
ee) .• -d, Columns with differcnc superscripts diU:er at p < 0.05. 
by e ither mimicking o r inhibiting T N F-induced responses (Table 
I). 
T he agonistic p55 an tibody Htr9 enhan ced collagen ase activity to 
a degree similar to th at enhanced by T NF, as is shown in Fig 2 . 
Because previo us reports indicate that T NFR antibodies cross-
linked by addition of secondary antibodies may mimic T NF ac tiv-
ities (Engelmann et ai, 1990; Espevik cl ai, 1990; L:egreid el ai, 
1994) , we exam ined whether addition of a secondary anti-l gG 
mo use antibody (Z412) together w ith the p75-specific MoAb 3H5 
could enhan ce the expressio n of collagenase . Afte r 48 h stimul ation 
wi th these two an tibodies together, no significa n t increase in 
collagenase activity was o bserved (Fig 2) . . Failure of stimul ation 
was also o bserved w ith the po lyclonal p75 antibody, K6 24 (Fig 2). 
The antagonistic p75 antibody 5E12 did n ot significantly afrect 
collagenase production by untreated cells o r ce lls treated with TNF 
(Fig 2) . Tn o the r experiments Htr9- treated cells showed a 6 .3-fo ld 
increase in immun oreactive collagenase and a 7-fold increase in 
collagenase activity. In addition , Htr9 enhanced stromelys in activ-
ity 3-fold over that of control , i.e., th e sam e increase as fo r TNF. 
T he Production of Collagenase Continued After the Re-
Inoval of TNF and Htr9 Both untreated and TN F- and Htr9-
treated fibrob lasts showed increas ing production of co llagenase 
with time (Table III). It is also notable tha t T NF and Htr9 induced 
production of similar amounts of collagenase (Table III) . After 
24 h sti mulation with T N F o r Htr9, the cells were washed three 
times with phosphate-buffered saline and subsequently incubated in 
serum-free m edium for 48 h to determine whether the production 
of coll agenase continued after the agonists were removed from the 
cultures. As shown in Table III, the cells pre-treated with T NF o r 
Htr9 for 24 h expressed approximately the same amount of 
collagenase after 48 h as did cell s continously treated w ith the two 
agonists. 
DISCUSSION 
Regulation of collagenase acti vity can occur by reduced gene 
expression by eith e r transcription o r trans lation (Birkedal-Hansen cI 
ai, 1.993), by activation or superactivation of the synthesized 
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Figurc 2. TNF-induccd collagcnase production is mcdiatcd 
through thc p55 reccptor. Human dermal fibrob lasts were stimu lated 
with TNF (10 ng per ml) or different antibodies for 48 h and tested for 
collagenase activity. TNF, the agonistic p55 antibody Htr9 (10 J.1g per ml), 
the agonistic p75 MoAb 3 h5 (10 J.1g per ml) and polyclonal K624 (di lu ted 
1/200) , and the antagollisti c p75 antibodies 5E12 (10 J.1g per ml) and Z4 I 2 
(rabbit-anti mouse immunoglobulin)(l 0 J.1g per ml) wcre all tested alone. In 
addition. some cul tures were treated with 3H5 in 1 h at 4°C. washed. and 
then incubated with Z412. 5E12 was also added I h prior to TNF in some 
cultures. R.esults are presented as relativc values (mean :!: SD) compared to 
UlIStimulated cell s (C) . ", Columns with relative va lues significantly differcnt 
from controls at p < 0.05. 
proenzym e (Murphy el ai, 1987; Unemori el ai, 1991) , or by 
inhibition of en zym e activity by ti ssue inhibi tors of matl;x m eta l-
loproteinases (Birkedal-Hansen el ai, 1993) . In the in vestigation of 
the ro les diffe rent cytokin es play in the regulation of collagen 
m e tabolism, it is the refore importan t to study the alte ration in 
collagenase activity as well as the m echanism unde.-lying the altered 
activity. T his study dem onstrates that human skin fibrobl asts ex-
posed to T N F produ ce increased immunoreactive procollagenase 
and show a simi lar increase in collagenase activity (Table II). T NF 
also en han ced the activity of stromelysin, a m atrix m etalloprotein-
ase that can superac ti va te coll agenase activity (Murphy e/ nl, 1987). 
Table III. The Prolonged Effect of TNF a nd Htr9 011 
Collagenase Prodnction b y Fibroblasts" 
Collagenase Activity: (mU)" 
Exposure 
Time (h) Controls TNF (10 ng/ ml) Htr9 (10 J.1g/ ml) 
24 l.S :!: 0. 1 39.2 :!: 2. 1' 36.4 :!: 0. 1' 
48 3.7 :!: 0.2 41.4 :!: 1.5' 42.0 :!: 0.7' 
72 4.8 :!: 0.7 53.2 :!: 1.8' 49.6 :!: 0.7' 
48" 44.8 :!: 2.5' 42.0 :!: 0.4' 
" Rcprcscmarivc experim ents showing: fibroblasts cull-ures stimulated wilh TNF or 
rile pSS :1I1tibody Htr9 for 24.48 :lI1d 72 h. T he coll agenase nctivity was determined by 
the dcgradntio l1 of reconstituted collngcll fibril s after illcubari011 ill 24 h at 35 D C. E:lch 
ge l contain ed 2500 Cplll .IS shown by toral degradation using bacteria l collagenase ill a 
fi nal concentration of 50 ILg/ml. 
/, Mean ::t SO. 
l' Compared wirh control p < 0.05. 
II Fibroblasts were pretreated with TNF or H tr9 fo r 24 h. rhen washed (3 X) and 
ill cuhillcd in SFM for <ldditiolla l 48 h. 
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T hese two matrix metall oproteinases are o ften co-regul ated simi-
larl y b y different cytokin es (B irkeda l-I-Iansen cl nl, 1993). The 
similar increm en t in procollagen ase protein and trypsin-ac tivated 
collagenase activity (Table II) indica tes that the ratio between 
stromel ys in and collagena se necessa ry for superactivation is main-
tained. 
T he specific ro les of the TNFRs p55 and p75 h ave not yet been 
fully e lu cidated (Tartaglia and Goeddel, 1992). Most effects ofTNF 
can be mediated by p55 (Vandenabeele cl nl, 1995) , and som e ca n 
also be mediated through p75 (Vandenabeele cl. nl, 1995). In this 
study the p55 antibody Htr9 and TNF induced a simil ar level of 
coll agenase expression, while p7 5 antibodies fa iled to enhan ce 
collagen ase expression . Moreover, an an tagonistic p75 antibody did 
not inhibit T NF-indu ced collagenase ac tivity. T hus, o ur data 
strongly suggest that the TNF-induced coll agenase production is 
m ediated only throu gh the p5 5 receptor. T herefore, the previo us 
o bservation (Westermarck cl nl, 1995) th at a p55-specific TNF 
mutant induced only 65% of collagen ase mRNA in fibrobla sts 
compared to w ild type TNF may be due to a lower effectiveness o f 
the TNF mutant. 
T NF in th e skin is produced b y k eratinocytes, fibroblasts, and 
infiltra tin g leukocytes (Vassalli , 1992; Piguet, 1993) . Although the 
ro le ofTNF in normal wound hea ling is not known, an ini tial burst 
ofTNF was observed in wound fluid at 24 h after injury (Bettinger, 
1994), sugges ting that TNF m ay play an important ro le in the early 
phase of the inflammatory response. We and others have shown 
earlier that TNF is chemotactic for both leukocytes and fibroblasts 
ill lI ii l'o (Ming el aI, 1987; Postletwaite and Seyer, 1990; R ekdal el nl, 
1994), w hich may be important in this early phase of wound 
healing, but higher concentrations of TN F are required for induc-
tion of collagenase production than for induction of chemotaxis 
(Chua and C hua, 1990; Postle twaite and Seyer , 1990). Cells 
relatively distan t from the site of TNF release may be exposed to 
low concentrations of T N F that indu ce their migration toward the 
site of inflammation. T he higher concen tra tion at the ir des tination 
ma y then increase production of coll agenase by the migra ted 
fibroblasts as a fi rst step in collagen degl'adation during ti ssue 
remodeling. Furthermore, our stud ies suggest that TNF ca uses 
prol on ged production of coll agenase by th e fibroblasts until several 
days afte r TNF is removed (Table III), further suggesting tha t 
TNF-induced extracellular matrix degradation ill v i vo can continue 
for several days after the initi al TNF burst. T herefore, it is possible 
th at efforts to prevent excessive conn ective ti ssue degradation 
should be based on e ither inhibition o f an intracellular signal 
pathway o r use of a specific inhibito r of collagenase, rather than o n 
attempts to block cytokin e action directly . 
In diseases with excessive accumulation of co ll agen resul ting in 
tissue fibros is (Kii hiiri, 1993 ; Kivirikko, 1993), enhan cem ent of the 
turnover of coll agenous connective ti ssue may be a useful part of 
the treatment. We have shown earlier that soluble p55 receptor 
inhibi ted the activity of a T NF 36-62 peptide in mimicking the 
chemotactic effect ofTNF on leukocytes (Rekdal el nl, 1994) . T his 
region is within a TNF (-;-agment 32-68 reported to be chemotactic 
fo r fibrob lasts (Postletwaite and Seyer, 1990) . Since our T N F 
36-62 peptide also ca used a pronounced increase in coll agenase 
activity , it mimics several impo rtant T N F bioactivities in different 
ce lls, but earlier studies revealed that this TNF 36-62 peptide does 
not imitate the cytotox ic effect ofTN F on a fibrosarcoma cell lin e 
(Rekdal ci nl, 1994). T his su gges ts the possibility of designing TNF 
peptides with some but not a ll of the ac tivities of TNF. Since 
murin e p55-specific agonists are about 50-fold less toxic than 
murine TNF when admini stered intravenously, it has been pro-
posed that a p55-specific TN F mutant w ith reduced systemic 
toxicity compared to TNF itself ma y be of therapeutic va lue 
(Westermarck ct nl, 1995). Since the p55 receptor mediates most of 
the efFects ofTNF (Vandenabeele ci nl, 1995) , however, it appears 
that des ign ofTNF peptides with diffe rentiated T N F effects such as 
chemotaxis and ability to enhance coll agenolytic activi ty may offer 
an alternative and possibly better approach for the development of 
therapeutic agents to treat fibrosis. 
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